AstraZeneca cuts 700 jobs. AstraZeneca says it
is eliminating about 700 jobs in its U.S. commercial business. The U.K. company said Thursday that the cuts affect about 120 people at its U.S. headquarters in Delaware. It also impacts sales and non-sales positions across the United States, and include roughly 80 vacant positions. The latest job cuts will leave AstraZeneca with about 1,500 employees in Delaware.